Robeco Institutional Asset Management
AGIO icon

Robeco Institutional Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Robeco Institutional Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,179
Closed -$181K – 934
2020
Q3 		$181K Hold
5,179
– – ﹤0.01% 850
2020
Q2 		$277K Buy
+5,179
New +$240K ﹤0.01% 863

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Robeco Institutional Asset Management's AGIO Position: Q4 2020 in Review

Robeco Institutional Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 5,179 shares — an estimated $181K sold.

Robeco Institutional Asset Management first reported a position in AGIO in Q2 2020 and held it in 2 quarters. The position peaked at $277K in Q2 2020. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Robeco Institutional Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 5,179 Agios Pharmaceuticals shares in Q4 2020, an estimated $181K.
  • Robeco Institutional Asset Management first reported a position in Agios Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Robeco Institutional Asset Management's Agios Pharmaceuticals position peaked at $277K in Q2 2020.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2020, filed 28 Jan 2021.